StonvexLoading…
StonvexStonvexStonvexCore line items from GTY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $221.73M | $203.39M | $185.85M | $165.59M |
Operating Income | $126.78M | $109.77M | $91.15M | $117.29M |
Net Income | $79.19M | $71.06M | $60.15M | $90.04M |
EPS (Diluted) | $1.35 | $1.25 | $1.15 | $1.88 |
Total Assets | $2.17B | $1.97B | $1.82B | $1.56B |
Total Liabilities | $1.10B | $1.01B | $866.75M | $802.45M |
Cash & Equivalents | $8.36M | $9.48M | $3.31M | $8.71M |
Free Cash Flow OCF − CapEx | $127.02M | $129.63M | $104.99M | Not available |
Shares Outstanding | 59.82M | 55.03M | 53.95M | 46.73M |